| | | | | | | | | | | | | | | | |
| | |
 | Issue Date FY: 2025 ( Subtotal = $2,301,112 ) |
| | 2025 | 2025 | CINCINNATI UNIV OF | 2600 CLIFTON AVE | CINCINNATI | OH | 45220-2872 | HAMILTON | USA | R61AI187097 | Development of a Molecular Toolbox for Pneumocystis | 000 | 1 | NIH | 11/15/2024 | $402,860 |
| | 2025 | 2025 | CINCINNATI UNIV OF | 2600 CLIFTON AVE | CINCINNATI | OH | 45220-2872 | HAMILTON | USA | R01HL168464 | A novel strategy for heart failure therapeutics | 000 | 2 | NIH | 11/8/2024 | $481,436 |
| | 2025 | 2025 | CINCINNATI UNIV OF | 2600 CLIFTON AVE | CINCINNATI | OH | 45220-2872 | HAMILTON | USA | R01GM144426 | Mechanistic role of phosphatidylinositol 5-phosphate 4-kinase beta in GTP-dependent lysosomal acidification for stress-resilient cell growth and metabolism | 000 | 3 | NIH | 11/15/2024 | $318,858 |
| | 2025 | 2025 | CINCINNATI UNIV OF | 2600 CLIFTON AVE | CINCINNATI | OH | 45220-2872 | HAMILTON | USA | R01HL160811 | Lcn10 in Sepsis-Induced Vascular Leakage and Heart Failure | 000 | 4 | NIH | 11/8/2024 | $612,216 |
| | 2025 | 2025 | CINCINNATI UNIV OF | 2600 CLIFTON AVE | CINCINNATI | OH | 45220-2872 | HAMILTON | USA | R21AI176276 | Early life dysbiosis, and skin barrier function | 000 | 2 | NIH | 10/31/2024 | $234,488 |
| | 2025 | 2025 | CINCINNATI UNIV OF | 2600 CLIFTON AVE | CINCINNATI | OH | 45220-2872 | HAMILTON | USA | R01HL156024 | Minocycline as a potential therapy for neuroinflammation and cognitive deficit in sickle cell disease | 001 | 6 | NIH | 11/14/2024 | $235,090 |
| | 2025 | 2025 | CINCINNATI UNIV OF | 2600 CLIFTON AVE | CINCINNATI | OH | 45220-2872 | HAMILTON | USA | R01HL156024 | Minocycline as a potential therapy for neuroinflammation and cognitive deficit in sickle cell disease | 000 | 6 | NIH | 11/12/2024 | $539,867 |
| | 2025 | 2024 | CINCINNATI UNIV OF | 2600 CLIFTON AVE | CINCINNATI | OH | 45220-2872 | HAMILTON | USA | R37DA057944 | Role of prelimbic cortical endocannabinoid signaling in enhanced cocaine-seeking behavior following combined repeated stress and cocaine use in rats | 000 | 1 | NIH | 11/6/2024 | $0 |
| | 2025 | 2024 | CINCINNATI UNIV OF | 2600 CLIFTON AVE | CINCINNATI | OH | 45220-2872 | HAMILTON | USA | U01NS086872 | NIH StrokeNet National Clinical Coordinating Center | 001 | 10 | NIH | 11/8/2024 | -$74,864 |
| | 2025 | 2024 | CINCINNATI UNIV OF | 2600 CLIFTON AVE | CINCINNATI | OH | 45220-2872 | HAMILTON | USA | U01NS086872 | NIH StrokeNet National Clinical Coordinating Center | 000 | 11 | NIH | 11/8/2024 | $74,864 |
| | 2025 | 2024 | CINCINNATI UNIV OF | 2600 CLIFTON AVE | CINCINNATI | OH | 45220-2872 | HAMILTON | USA | R35GM128837 | The crosstalk of organelles involved in autophagosome biogenesis | 000 | 6 | NIH | 11/14/2024 | $0 |
| | 2025 | 2024 | CINCINNATI UNIV OF | 2600 CLIFTON AVE | CINCINNATI | OH | 45220-2872 | HAMILTON | USA | UL1TR001425 | Center for Clinical and Translational Science and Training | 000 | 9 | NIH | 11/1/2024 | $0 |
| | 2025 | 2024 | CINCINNATI UNIV OF | 2600 CLIFTON AVE | CINCINNATI | OH | 45220-2872 | HAMILTON | USA | R35GM134923 | Structural/functional characterization of TGFβ superfamily signaling and regulation | 000 | 5 | NIH | 11/6/2024 | $0 |
| | 2025 | 2024 | CINCINNATI UNIV OF | 2600 CLIFTON AVE | CINCINNATI | OH | 45220-2872 | HAMILTON | USA | R35GM149538 | Novel regulators of macrophage function to repair sterile inflammation-induced heart injury | 000 | 2 | NIH | 11/5/2024 | $0 |
| | 2025 | 2024 | CINCINNATI UNIV OF | 2600 CLIFTON AVE | CINCINNATI | OH | 45220-2872 | HAMILTON | USA | K01OH012549 | Using Cognitive-Behavioral Change and Mobile Technology to Improve RN Sleep and Fatigue | 01 | 2 | CDC | 10/24/2024 | $0 |
| | 2025 | 2023 | CINCINNATI UNIV OF | 2600 CLIFTON AVE | CINCINNATI | OH | 45220-2872 | HAMILTON | USA | K23NS113858 | Blood Pressure after Endovascular Stroke Therapy-II: A Randomized Trial | 000 | 6 | NIH | 11/15/2024 | $0 |
| | 2025 | 2023 | CINCINNATI UNIV OF | 2600 CLIFTON AVE | CINCINNATI | OH | 45220-2872 | HAMILTON | USA | R01HL148598 | Regulators of extracellular matrix production during cardiac development and disease | 000 | 4 | NIH | 10/28/2024 | -$399,659 |
| | 2025 | 2023 | CINCINNATI UNIV OF | 2600 CLIFTON AVE | CINCINNATI | OH | 45220-2872 | HAMILTON | USA | K01OH012549 | Using Cognitive-Behavioral Change and Mobile Technology to Improve RN Sleep and Fatigue | 01 | 2 | CDC | 10/24/2024 | $0 |
| | 2025 | 2022 | CINCINNATI UNIV OF | 2600 CLIFTON AVE | CINCINNATI | OH | 45220-2872 | HAMILTON | USA | R21AI160722 | Immunopathogenesis of Histoplasmosis and TNF | 000 | 2 | NIH | 10/30/2024 | $0 |
| | 2025 | 2022 | CINCINNATI UNIV OF | 2600 CLIFTON AVE | CINCINNATI | OH | 45220-2872 | HAMILTON | USA | R01NS103981 | Regulation of Lipid Catabolism by Autophagy in Neural Stem Cell of Tuberous Sclerosis Complex | 000 | 5 | NIH | 11/12/2024 | $0 |
| | 2025 | 2022 | CINCINNATI UNIV OF | 2600 CLIFTON AVE | CINCINNATI | OH | 45220-2872 | HAMILTON | USA | U24NS100688 | Strategies to Innovate EmeRgENcy Care Clinical Trials Network ("SIREN") - Supplement | 000 | 5 | NIH | 10/16/2024 | -$2,404 |
| | 2025 | 2021 | CINCINNATI UNIV OF | 2600 CLIFTON AVE | CINCINNATI | OH | 45220-2872 | HAMILTON | USA | U4E42429 | Nurse Education Practice Quality Retention Simulation Education Training | 03 | 1 | HRSA | 10/2/2024 | $0 |
| | 2025 | 2021 | CINCINNATI UNIV OF | 2600 CLIFTON AVE | CINCINNATI | OH | 45220-2872 | HAMILTON | USA | U01DA048525 | First-In-Human Study of a Humanized Anti-Cocaine Monoclonal Antibody | 000 | 3 | NIH | 11/6/2024 | $0 |
| | 2025 | 2019 | CINCINNATI UNIV OF | 2600 CLIFTON AVE | CINCINNATI | OH | 45220-2872 | HAMILTON | USA | R01NS113243 | Targeting sensory ganglia and glial signaling for the treatment of acute and chronic pain | 000 | 1 | NIH | 10/1/2024 | -$121,640 |
|
| Issue Date FY: 2024 ( Subtotal = $107,945,265 ) (Continued on the next page) |
| | 2024 | 2024 | CINCINNATI UNIV OF | 2600 CLIFTON AVE | CINCINNATI | OH | 45220-2872 | HAMILTON | USA | R01DK136632 | Histone chaperones and cell state regulation | 001 | 1 | NIH | 8/22/2024 | $53,484 |
| | 2024 | 2024 | CINCINNATI UNIV OF | 2600 CLIFTON AVE | CINCINNATI | OH | 45220-2872 | HAMILTON | USA | R37CA284033 | RepurPosed AntiretrOviraL ThErapieS to EliminAte Cervical Cancer (POLESA Trial) | 001 | 2 | NIH | 7/31/2024 | $456,279 |
| | 2024 | 2024 | CINCINNATI UNIV OF | 2600 CLIFTON AVE | CINCINNATI | OH | 45220-2872 | HAMILTON | USA | R01AI158451 | Regulation of C. difficile colitis by host genetic and immune factors | 000 | 4 | NIH | 8/13/2024 | $405,000 |
| | 2024 | 2024 | CINCINNATI UNIV OF | 2600 CLIFTON AVE | CINCINNATI | OH | 45220-2872 | HAMILTON | USA | R35GM128837 | The crosstalk of organelles involved in autophagosome biogenesis | 000 | 6 | NIH | 9/4/2024 | $405,000 |
| | 2024 | 2024 | UNIVERSITY OF CINCINNATI | 2600 CLIFTON AVE | CINCINNATI | OH | 45220-2872 | HAMILTON | USA | R01HL105826 | Fast myosin binding protein-C and cardiac contractility in heart failure | 000 | 11 | NIH | 12/18/2023 | $405,000 |
| | 2024 | 2024 | UNIVERSITY OF CINCINNATI | 2600 CLIFTON AVE | CINCINNATI | OH | 45220-2872 | HAMILTON | USA | R01NS134804 | Developing multi-cue piezoelectric PVDF-TrFE biomaterials for peripheral nerve repair | 000 | 1 | NIH | 12/26/2023 | $441,060 |
| | 2024 | 2024 | UNIVERSITY OF CINCINNATI | 2600 CLIFTON AVE | CINCINNATI | OH | 45220-2872 | HAMILTON | USA | R01CA197865 | Role of MED1 in HER2-mediated tumorigenesis | 000 | 9 | NIH | 3/14/2024 | $346,275 |
| | 2024 | 2024 | CINCINNATI UNIV OF | 2600 CLIFTON AVE | CINCINNATI | OH | 45220-2872 | HAMILTON | USA | 90DDUC0111 | University Centers for Excellence in Developmental Disabilities Education, Research and Service | 00 | 3 | ACL | 6/26/2024 | $620,675 |
| | 2024 | 2024 | CINCINNATI UNIV OF | 2600 CLIFTON AVE | CINCINNATI | OH | 45220-2872 | HAMILTON | USA | R01NR019531 | Identification of causal factors underlying cognitive deficits in a mouse model of childhood leukemia survival | 001 | 5 | NIH | 6/17/2024 | $529,549 |
| | 2024 | 2024 | UNIVERSITY OF CINCINNATI | 2600 CLIFTON AVE | CINCINNATI | OH | 45220-2872 | HAMILTON | USA | R01CA197865 | Role of MED1 in HER2-mediated tumorigenesis | 001 | 9 | NIH | 4/17/2024 | $19,238 |
| | 2024 | 2024 | CINCINNATI UNIV OF | 2600 CLIFTON AVE | CINCINNATI | OH | 45220-2872 | HAMILTON | USA | R01NS134804 | Developing multi-cue piezoelectric PVDF-TrFE biomaterials for peripheral nerve repair | 001 | 1 | NIH | 7/16/2024 | $0 |
| | 2024 | 2024 | CINCINNATI UNIV OF | 2600 CLIFTON AVE | CINCINNATI | OH | 45220-2872 | HAMILTON | USA | R01AG072592 | Cerebral small vessel disease burden and racial disparity in vascular cognitive impairment and Alzheimer’s disease and its related dementias | 000 | 4 | NIH | 5/31/2024 | $1,233,404 |
| | 2024 | 2024 | CINCINNATI UNIV OF | 2600 CLIFTON AVE | CINCINNATI | OH | 45220-2872 | HAMILTON | USA | R01HD098757 | Estracellular Vesicles as Non-Invasive Predictors of Antidepressant Outcomes in Pediatric Anxiety | 000 | 5 | NIH | 8/22/2024 | $454,389 |
| | 2024 | 2024 | CINCINNATI UNIV OF | 2600 CLIFTON AVE | CINCINNATI | OH | 45220-2872 | HAMILTON | USA | R01NS128425 | CAPSTONE: Central And Peripheral STrOke inflammatioN with Exosomes | 000 | 3 | NIH | 7/16/2024 | $604,864 |
| | 2024 | 2024 | CINCINNATI UNIV OF | 2600 CLIFTON AVE | CINCINNATI | OH | 45220-2872 | HAMILTON | USA | R01NS128425 | CAPSTONE: Central And Peripheral STrOke inflammatioN with Exosomes | 000 | 3 | NIH | 7/16/2024 | $22,825 |
| | 2024 | 2024 | CINCINNATI UNIV OF | 2600 CLIFTON AVE | CINCINNATI | OH | 45220-2872 | HAMILTON | USA | R01NS128425 | CAPSTONE: Central And Peripheral STrOke inflammatioN with Exosomes | 000 | 3 | NIH | 7/16/2024 | $133,144 |
| | 2024 | 2024 | CINCINNATI UNIV OF | 2600 CLIFTON AVE | CINCINNATI | OH | 45220-2872 | HAMILTON | USA | F31HL175976 | The Role of Platelet-Derived Transforming Growth Factor Beta in Abdominal Aortic Aneurysm | 000 | 1 | NIH | 8/20/2024 | $48,960 |
| | 2024 | 2024 | CINCINNATI UNIV OF | 2600 CLIFTON AVE | CINCINNATI | OH | 45220-2872 | HAMILTON | USA | R21AI178573 | Barcode screening of essential protein kinases in the life cycle progression of Trypanosoma cruzi | 000 | 2 | NIH | 7/17/2024 | $243,000 |
| | 2024 | 2024 | UNIVERSITY OF CINCINNATI | 2600 CLIFTON AVE | CINCINNATI | OH | 45220-2872 | HAMILTON | USA | R21DC021537 | Improving the accessibility of transgender voice training with visual-acoustic biofeedback | 000 | 1 | NIH | 11/27/2023 | $213,878 |
| | 2024 | 2024 | CINCINNATI UNIV OF | 2600 CLIFTON AVE | CINCINNATI | OH | 45220-2872 | HAMILTON | USA | F31HL175976 | The Role of Platelet-Derived Transforming Growth Factor Beta in Abdominal Aortic Aneurysm | 001 | 1 | NIH | 8/20/2024 | $0 |
| | 2024 | 2024 | UNIVERSITY OF CINCINNATI | 2600 CLIFTON AVE | CINCINNATI | OH | 45220-2872 | HAMILTON | USA | U01NS120910 | Validation of Early Prognostic Data for Recovery Outcomes after Stroke for Future, Higher Yield Trials (VERIFY) | 002 | 3 | NIH | 5/1/2024 | $187,340 |
| | 2024 | 2024 | CINCINNATI UNIV OF | 2600 CLIFTON AVE | CINCINNATI | OH | 45220-2872 | HAMILTON | USA | UL853311 | Integrating Behavioral Health into Primary Care through Telehealth Evidence-Based Telehealth Network | 00 | 1 | HRSA | 9/6/2024 | $350,000 |
| | 2024 | 2024 | UNIVERSITY OF CINCINNATI | 2600 CLIFTON AVE | CINCINNATI | OH | 45220-2872 | HAMILTON | USA | U01NS120910 | Validation of Early Prognostic Data for Recovery Outcomes after Stroke for Future, Higher Yield Trials (VERIFY) | 001 | 3 | NIH | 1/31/2024 | $2,408,658 |
| | 2024 | 2024 | CINCINNATI UNIV OF | 2600 CLIFTON AVE | CINCINNATI | OH | 45220-2872 | HAMILTON | USA | F31HL170534 | The role of PAR2 and HuR in programming atherosclerotic vascular smooth muscle cells | 000 | 2 | NIH | 8/9/2024 | $37,445 |
|
